Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs.

Dignass A, Waller J, Cappelleri JC, Modesto I, Kisser A, Dietz L, DiBonaventura M, Wood R, May M, Libutzki B, Bargo D.

J Med Econ. 2020 Jan 15:1-13. doi: 10.1080/13696998.2019.1707210. [Epub ahead of print]

PMID:
31858853
2.

Single-step scaffold-based cartilage repair in the knee: A systematic review.

Fischer S, Kisser A.

J Orthop. 2016 Jun 25;13(4):246-53. doi: 10.1016/j.jor.2016.06.004. eCollection 2016 Dec. Review.

3.

Factors influencing coverage decisions on medical devices: A retrospective analysis of 78 medical device appraisals for the Austrian hospital benefit catalogue 2008-2015.

Kisser A, Tüchler H, Erdös J, Wild C.

Health Policy. 2016 Aug;120(8):903-12. doi: 10.1016/j.healthpol.2016.06.007. Epub 2016 Jun 16.

PMID:
27344197
4.

Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.

Siebert U, Jahn B, Rochau U, Schnell-Inderst P, Kisser A, Hunger T, Sroczynski G, Mühlberger N, Willenbacher W, Schnaiter S, Endel G, Huber L, Gastl G; Oncotyrol HTA & Outcomes Research Working Group.

Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):330-40. doi: 10.1016/j.zefq.2015.06.012. Epub 2015 Jul 28.

PMID:
26354133
5.

The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells.

Dufner A, Kisser A, Niendorf S, Basters A, Reissig S, Schönle A, Aichem A, Kurz T, Schlosser A, Yablonski D, Groettrup M, Buch T, Waisman A, Schamel WW, Prinz M, Knobeloch KP.

Nat Immunol. 2015 Sep;16(9):950-60. doi: 10.1038/ni.3230. Epub 2015 Jul 27.

PMID:
26214742
6.

A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.

Kisser A, Zechmeister-Koss I.

BJOG. 2015 Jan;122(1):64-70. doi: 10.1111/1471-0528.13076. Epub 2014 Sep 11. Review.

7.

Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries.

Kisser A, Heininger U, Moorthy VS, Akanmori BD, Leroy O.

Vaccine. 2011 May 31;29(24):4173-4. doi: 10.1016/j.vaccine.2011.03.008. Epub 2011 Apr 5. No abstract available.

PMID:
21473949
8.

Towards validated assays for key immunological outcomes in malaria vaccine development.

OPTIMALVAC consortium, Cavanagh DR, Dubois PM, Holtel A, Kisser A, Leroy O, Locke E, Moorthy VS, Remarque EJ, Shi YP.

Vaccine. 2011 Apr 12;29(17):3093-5. doi: 10.1016/j.vaccine.2011.01.070. Epub 2011 Feb 4. No abstract available.

9.

Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo.

Niendorf S, Oksche A, Kisser A, Löhler J, Prinz M, Schorle H, Feller S, Lewitzky M, Horak I, Knobeloch KP.

Mol Cell Biol. 2007 Jul;27(13):5029-39. Epub 2007 Apr 23.

10.

Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice.

Knobeloch KP, Utermöhlen O, Kisser A, Prinz M, Horak I.

Mol Cell Biol. 2005 Dec;25(24):11030-4.

Supplemental Content

Loading ...
Support Center